What's interesting about this survey, I think, is that the perceived benefit of patient technologies and virtual trials are focused very much on the patients and data collection, while the barriers are primarily of organizational, regulatory, and technical character. With patient recruitment and retention being the most cited challenges of trial execution, there should be a solid case for implementing more virtual elements into future trials.